RecruitingPhase 2NCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Principal Investigator
Sabrina Hoa, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Intervention
Mycophenolate Mofetil(drug)
Enrollment
35 enrolled
Eligibility
18 years · All sexes
Timeline
2024 – 2028

Study locations (3)

Collaborators

McGill University · University of Calgary · Jewish General Hospital · Canadian Institutes of Health Research (CIHR) · Sclérodermie Québec · Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05785065 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials